Annovis Bio, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Annovis Bio, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (8)
Annovis Bio, Inc. made a loss over the last year. Annovis Bio, Inc. owes $1.19 for every $1 it owns. Annovis Bio, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossAnnovis Bio, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-9.95Annovis Bio, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$42 MThe total market value of all of Annovis Bio, Inc.'s shares at today's price (share price × number of shares), smaller than 76% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
NegativeAnnovis Bio, Inc.'s net worth is negative ($4 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Return on equity (ROE)
-703.7%Annovis Bio, Inc. lost 703.7% of its shareholders' money over the last year, lower than 96% of Healthcare companies in United States.
Owes vs Owns
1.19×Annovis Bio, Inc. owes $1.19 for every $1 it owns, so it owes more than it owns, higher than 91% of Healthcare companies in United States.
Dividend yield
NoneAnnovis Bio, Inc. does not currently pay a dividend.
Profit growth
LossAnnovis Bio, Inc. made a loss in each of the last two years.
Questions
What is Annovis Bio, Inc.'s return on equity?
Annovis Bio, Inc. lost 703.7% of its shareholders' money over the last year, lower than 96% of Healthcare companies in United States.
How much does Annovis Bio, Inc. owe compared with what it owns?
Annovis Bio, Inc. owes $1.19 for every $1 it owns, so it owes more than it owns, higher than 91% of Healthcare companies in United States.
Does Annovis Bio, Inc. pay a dividend?
No. Annovis Bio, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.